Analysis of clinical characteristics of 554 patients with IgA nephropathy

Analysis of clinical characteristics of 554 patients with IgA nephropathy

Objective To investigate the characteristics of IgA nephropathy and clinical characteristics of different stages of renal function. Methods A total of 554 patients with clinical biopsy-proven IgA nephropathy were included in this study. Baseline clinical and laboratory data were collected. The compo...

Full description

Bibliographic Details
Main Author:	Chen Jiexin, Tang Ruiying, Liang Bo, Xu Qingdong
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of New Medicine 2022-06-01
Series:	Xin yixue
Subjects:	\|iga nephropathy\|progression of renal function\|proteinuria\|uric acid
Online Access:	https://www.xinyixue.cn/fileup/0253-9802/PDF/1658129417413-1816392953.pdf

Similar Items

Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria
by: Ding Chen, et al.
Published: (2018-03-01)

Iga nephropathy
by: Basta-Jovanović Gordana M.
Published: (2004-01-01)

IgA Nephropathy Secondary to Ipilimumab Use
by: Sean C. Dougherty, et al.
Published: (2021-11-01)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
by: Min Tan, et al.
Published: (2019-01-01)

The case of nutcracker phenomenon associated with IgA nephropathy
by: Medin Danilo V., et al.
Published: (2021-01-01)

Iga nephropathy: clinical-morphologic correlation
by: Basta-Jovanović Gordana M., et al.
Published: (2003-01-01)

Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
by: Zhaohui Ni, et al.
Published: (2021-01-01)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022-05-01)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
by: Dita Maixnerova, et al.
Published: (2021-09-01)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01)

Serum uric acid level is correlated with the clinical, pathological progression and prognosis of IgA nephropathy: an observational retrospective pilot-study
by: Pingfan Lu, et al.
Published: (2020-11-01)

Role of corticosteroid therapy in IgA nephropathy; where do we stand?
by: Shankar Prasad Nagaraju, et al.
Published: (2017-10-01)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
by: Dongqing Wang, et al.
Published: (2023-03-01)

Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
by: Andrzej Konieczny, et al.
Published: (2021-09-01)

Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy
by: Bhanu Prasad, et al.
Published: (2018-05-01)

The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy
by: Yasar Caliskan, et al.
Published: (2016-02-01)

IgA nephropathy presenting with pulmonary thromboembolism and renal artery infarct
by: Madhav Venkatesan, et al.
Published: (2019-07-01)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
by: Ya-zi Yang, et al.
Published: (2019-08-01)

Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
by: Qi Chen, et al.
Published: (2022-05-01)

Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study
by: Ya Hu, et al.
Published: (2023-12-01)

Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary
by: Hirokazu Marumoto, et al.
Published: (2020-09-01)

Clinicopathological Features and Outcomes of IgA Nephropathy with Hematuria and/or Minimal Proteinuria
by: Min Tan, et al.
Published: (2015-04-01)

Efficacy and Safety of Agents in IgA Nephropathy: An Update Network Meta-Analysis
by: Pingping Yang, et al.
Published: (2018-12-01)

Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study
by: Chen Tang, et al.
Published: (2020-11-01)

Crescents and IgA Nephropathy: A Delicate Marriage
by: Hernán Trimarchi, et al.
Published: (2022-06-01)

Distinct characteristics and prognosis of IgA nephropathy patients with nephrotic syndrome: a propensity score-matched cohort study
by: Yuanyuan Jiang, et al.
Published: (2024-02-01)

Corrigendum: Distinct characteristics and prognosis of IgA nephropathy patients with nephrotic syndrome: a propensity score-matched cohort study
by: Yuanyuan Jiang, et al.
Published: (2024-04-01)

IgA nephropathy: a review of existing and emerging therapies
by: Sahibzadi Mahrukh Noor, et al.
Published: (2023-05-01)

Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review
by: Hormat Rahimzadeh, et al.
Published: (2023-04-01)

Three-Year Clinical Outcomes of the First South Asian Prospective Longitudinal Observational IgA Nephropathy Cohort
by: Suceena Alexander, et al.
Published: (2022-02-01)

Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study
by: Feng-Lei Si, et al.
Published: (2023-06-01)

Life Expectancy for Patients From the Southeastern United States With IgA Nephropathy
by: M. Colleen Hastings, et al.
Published: (2018-01-01)

Machine Learning in Prediction of IgA Nephropathy Outcome: A Comparative Approach
by: Andrzej Konieczny, et al.
Published: (2021-04-01)

Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
by: Lijuan Zhao, et al.
Published: (2023-05-01)

Half a century of IgA nephropathy: achievements, frustrations and challenges
by: I.I. Lapchynska
Published: (2018-09-01)

Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis
by: Dongxu Zhang, et al.
Published: (2024-03-01)

Secondary Publication: Clinical Grade of IgA Nephropathy
by: Takahito Moriyama, et al.
Published: (2020-03-01)

Treatment of rapidly progressive IgA nephropathy with glucocorticoid plus telitacicept: one case report
by: Jia-xin Huang, et al.
Published: (2024-04-01)

Clinicopathological characteristics and prognosis of patients with IgA nephropathy and renal vasculitic lesions
by: Xueqing Tang, et al.
Published: (2021-10-01)

The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy
by: Rafaela C.G. Fabiano, et al.
Published: (2017-07-01)